+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
ID07215780

SORE Study Sitz Baths After Urogynecologic Reconstruction

Led by Yale University · Updated on 2025-12-03

112

Participants Needed

4

Research Sites

13 weeks

Total Duration

On this page

Sponsors

Y

Yale University

Lead Sponsor

A

American Urogynecologic Society

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying women undergoing surgical repair of pelvic organ prolapse to evaluate how effective postoperative sitz baths are in managing pain and aiding recovery. This prospective, randomized controlled trial, called the SORE Study, compares the pain intensity reported one week after native tissue repair between patients using a sitz bath regimen and those receiving usual care. The study also aims to explore patient satisfaction with pain management, opioid use, healthcare visits, adherence to pain plans, and healing complications. Participants are assigned to one of two groups one group uses warm water sitz baths nightly for seven days after surgery along with usual care, while the other group receives usual care without sitz baths. The sitz bath involves soaking in warm water for 10 minutes each night. The study begins soon after surgery and includes a week of intervention and follow-up. Throughout the study, participants will complete questionnaires about their pain levels and satisfaction with pain management on day 7 after surgery. Researchers will track opioid use, adherence to the sitz bath regimen, any barriers to its use, rare adverse effects, and the number of calls or emergency visits related to pain up to 90 days after surgery. The total participation duration includes the initial week of treatment and monitoring up to 90 days for safety and healthcare use.

CONDITIONS

Brief Title

SORE Study: Sitz Baths After Urogynecologic Reconstruction

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female 18 years of age or older at the time of surgery
  • English or Spanish-speaking
  • Documented pelvic organ prolapse Stage 2, 3, or 4 by POP-Q examination
  • Surgery performed by a urogynecologist
  • Ambulatory or inpatient surgery accepted
Not Eligible

You will not qualify if you...

  • Mesh-augmented prolapse repair (robotic, laparoscopic, open sacrocolpopexy or sacrohysteropexy, vaginal mesh)
  • Urogynecologic surgery without prolapse repair (e.g., midurethral sling, intravesicular botox, hysterectomy only)
  • Suspected genital herpes, molluscum contagiosum, condyloma acuminata, or vulvar/vaginal skin infections at recruitment
  • Daily opioid use (short or long-acting)
  • Concurrent non-urogynecologic surgery (e.g., rectopexy, cancer staging or debulking)
  • Lack of access to operative report
  • Pregnant at the time of surgery
  • Incarcerated
  • Unable to give consent or have a legal guardian
  • Unable to complete study intervention or assessments as judged by investigators

Research Team

M

Melissa Markowitz, MD

K

Koray Gorkem Sacinti, MD, MPH

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here